Qualigen Therapeutics, Inc.
About Us
Our Company
Leadership
Why We Do It
Board of Directors
Careers at Qualigen
Contact Us
Therapeutics
Pipeline
AS1411
ALAN
ALAN-RE
ALAN-CE
RAS-F
STARS
Resource Literature
AS1411 Resource Literature
RAS Resource Literature
Diagnostics
FastPack® IP
Patients
Clinical Trials
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Customer Support
Ordering
Technical Support
SDS
OnQ Training
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-K
10-K/A
10-KT
10-Q
3
3/A
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
EFFECT
FWP
NT 10-K
POS AM
PRE 14A
PRER14A
REGDEX
S-1
S-1/A
S-1MEF
S-3
S-4
S-4/A
S-4MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2010
2009
Date
Form
Description
PDF
XBRL
Pages
06/01/20
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
06/01/20
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
7
05/29/20
8-K
Current report filing
4
05/29/20
8-K
Current report filing
Documents
EX-2.4
EX-3.1
EX-3.2
EX-3.3
EX-3.4
EX-3.5
EX-3.6
EX-10.1
EX-10.2
EX-10.3
EX-10.6
EX-10.7
EX-10.8
EX-10.9
EX-10.10
EX-10.11
EX-10.12
EX-10.13
EX-10.14
EX-10.15
EX-10.16
EX-10.17
EX-10.18
EX-10.19
EX-10.20
EX-10.21
EX-10.22
EX-14.1
EX-99.1
382
05/28/20
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
05/27/20
3
Initial statement of beneficial ownership of securities
1
05/27/20
4
Statement of changes in beneficial ownership of securities
2
05/27/20
4
Statement of changes in beneficial ownership of securities
2
05/27/20
4
Statement of changes in beneficial ownership of securities
2
05/27/20
4
Statement of changes in beneficial ownership of securities
2
Previous
1
2
3
4
5
6
7
8
9
10
…42
Next
Email Alerts
Tear Sheet
Contacts
RSS News Feed